These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17391426)

  • 1. Comment on "Where's the value in health care"?
    Lungen M; Gerber A
    Value Health; 2007; 10(2):170; author reply 171. PubMed ID: 17391426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 3. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Menkes DB; Woodall AA
    N Z Bioeth J; 2003 Oct; 4(3):22, 24-5. PubMed ID: 15597480
    [No Abstract]   [Full Text] [Related]  

  • 4. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
    Richardson JR; Olsen JA
    Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHARMAC responds to Richard Milne on discounting health benefits and costs.
    Metcalfe S; Brougham M; Moodie P; Grocott R
    N Z Med J; 2005 Jul; 118(1219):U1600. PubMed ID: 16059415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychiatrists - gatekeepers guarding welfare state benefits?].
    Schomerus G; Spindler P; Bröker F
    Psychiatr Prax; 2005 May; 32(4):161-2. PubMed ID: 15852206
    [No Abstract]   [Full Text] [Related]  

  • 7. [More than "cheap copies". Generic drugs promote medical progress].
    MMW Fortschr Med; 2004 Jun; 146(24):51. PubMed ID: 15366498
    [No Abstract]   [Full Text] [Related]  

  • 8. [Direct purchase of expensive medicine from the manufacturer may be required].
    Zimmermann GW
    MMW Fortschr Med; 2015 Jun; 157(11):12. PubMed ID: 26049324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comment on IOWiG report plan. A medical decision may not be replaced].
    Vorstand der Deutschen Hochdruckliga E.V
    MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705
    [No Abstract]   [Full Text] [Related]  

  • 10. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Adams J
    N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
    [No Abstract]   [Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lean years for patients].
    Klose G; Anlauf M
    MMW Fortschr Med; 2004 Dec; 146(51-52):16. PubMed ID: 15675237
    [No Abstract]   [Full Text] [Related]  

  • 13. [The new drug cost saving package. Sensible measures or risk for patients?].
    Krankenpfl J; 2002; 40(5-6):159. PubMed ID: 12271499
    [No Abstract]   [Full Text] [Related]  

  • 14. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
    MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
    [No Abstract]   [Full Text] [Related]  

  • 15. Propaganda or the cost of innovation? Challenging the high price of new drugs.
    Ghinea N; Lipworth W; Kerridge I
    BMJ; 2016 Mar; 352():i1284. PubMed ID: 26968991
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug costs in Germany: 12 poorer countries are the benchmark].
    Laschet H
    MMW Fortschr Med; 2012 Nov; 154(21):12. PubMed ID: 23270047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can physicians really save still more in drug prescriptions?].
    Schmidt K
    MMW Fortschr Med; 2006 Feb; 148(5):44-5. PubMed ID: 16518938
    [No Abstract]   [Full Text] [Related]  

  • 18. [A big step in the direction of more competition].
    Schmidt K
    MMW Fortschr Med; 2007 Oct; 149(40):52. PubMed ID: 18018512
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference based pricing for provincial drug benefit programs.
    McLaughlin PR
    Can J Cardiol; 1996 Jan; 12(1):16, 25-6. PubMed ID: 8595565
    [No Abstract]   [Full Text] [Related]  

  • 20. [GMG and Epilepsy patient--sequelae for therapeutic nursing].
    Stefan H
    Krankenpfl J; 2004; 42(3-4):111-2. PubMed ID: 15311908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.